SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 6th, 2024 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May [ ], 2024, between T2 Biosystems, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ContractPlacement Agency Agreement • May 6th, 2024 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • New York
Subject to the terms and conditions of this letter agreement (the “Agreement”) between A.G.P./Alliance Global Partners (the “Placement Agent”), as sole placement agent, and T2 Biosystems, Inc., a Delaware corporation (the “Company”), the parties hereby agree that the Placement Agent shall serve as the placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed offering (the “Placement”) of securities of the Company, consisting of: (i) shares of common stock, par value $0.001 per share (“Common Stock”), (ii) pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), (iii) Series B-1 warrants to purchase shares of Common Stock (the “Series B-1 Warrants”) and (iv) Series B-2 warrants to purchase shares of Common Stock (the “Series B-2 Warrants” and collectively with the Pre-Funded Warrants and the Series B-1 Warrants, the “Warrants”). The Common Stock and Warrants actually sold by the Placement Agent are referred to herei
PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK T2 BIOSYSTEMS, INC.Pre-Funded Warrant • May 6th, 2024 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus
THIS PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from T2 Biosystems, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
